Publications by authors named "Guang-Ling Liu"
Background: Excessive proliferation and migration of airway smooth muscle cells (ASMCs) directly lead to airway remodeling in asthma. However, the role of circular RNAs (circRNAs) in airway remodeling remains unclear. This study aimed to investigate the regulatory role and mechanism of circ_CSNK1E in ASMCs proliferation and migration.
View Article and Find Full Text PDFProtective effects of sinomenine against doxorubicin-induced nephrosis in rats.
J Asian Nat Prod Res
October 2012
Article Synopsis
- * In the study, DOX induced nephrosis in rats, and administering SN helped improve urine and serum biochemical parameters as well as decrease inflammatory markers like TNF-α and IL-1β.
- * SN treatment also preserved important protein expressions in the kidneys, specifically nephrin and podocin, and reduced structural damage to podocytes, indicating its potential as a protective agent against nephrotic syndrome.
The co-transcription factor peroxisome proliferator-activated receptor γ coactivator-1β (PGC-1β) was first identified in 2002. Although the function of PGC-1β in white adipose tissue (WAT) is largely unknown, it has been studied extensively in the liver, cardiac muscle, and skeletal muscle. Herein, we investigated PGC-1β overexpression in 3T3-L1 adipocytes.
View Article and Find Full Text PDFObjective: To explore the effect of urokinase and low molecular weight heparin in children with nephrotic syndrome complicated with intracranial venous thrombosis.
Methods: Urokinase and low molecular weight heparin were administered to the 5 patients intravenously. The initial dose of urokinase was 2000 - 4000 U/(kg.
[Clinical and pathological study of 47 cases with Alport syndrome].
Zhonghua Er Ke Za Zhi
December 2008
Objective: To analyze the clinical and pathological features of children with Alport syndrome (AS).
Methods: A series of 47 patients with AS from unrelated families hospitalized from Jan. 1990 to Jan.
[Cyclosporin A treatment of 83 children with nephrotic syndrome of different pathological types].
Zhonghua Er Ke Za Zhi
November 2003
Objective: To evaluate the efficacy of cyclosporin A (CyA) therapy in 83 children with nephrotic syndrome of different pathological types.
Methods: Eighty-three children enrolled in this study were all hospitalized children with idiopathic nephrotic syndrome, aged 3 to 14 yrs (average 8.3 yrs) and included 52 males and 31 females.